802
Participants
Start Date
March 29, 2023
Primary Completion Date
August 25, 2025
Study Completion Date
August 25, 2025
0.5 ml dose of 1.1 mcg VAX-24
24 valent pneumococcal conjugate vaccine
0.5 ml dose of PCV20
20 valent pneumococcal conjugate vaccine
0.5 ml dose of 2.2 mcg VAX-24
24 valent pneumococcal conjugate vaccine
0.5 ml dose of 2.2/4.4 mcg VAX-24
24 valent pneumococcal conjugate vaccine
UPMC Children's Community Pediatrics South Hills-Jefferson Hills, Jefferson Hills
UPMC Primary Care Center Oakland, Pittsburgh
UPMC Children's Community Pediatrics Bass Wolfson-Squirrel Hill, Pittsburgh
UPMC Children's Community Pediatrics-Castle Shannon, Pittsburgh
UPMC Bass Wolfson Cranberry, Cranberry Township
Allegheny Health and Wellness Pavilion, Erie
Pediatric Research of Charlottesville, LLC, Charlottesville
Palmetto Pediatrics, PA, North Charleston
Coastal Pediatric Research, Summerville
Tribe Clinical Research at Parkside Pediatrics, Simpsonville
Jedidiah Clinical Research, Tampa
Holston Medical Group, Kingsport
Kentucky Pediatric/ Adult Research, Bardstown
Ohio Pediatric Research Assn., Dayton
Midwest Children's Health Research Institute, Lincoln
Midwest Children's Health Research Institute, Lincoln
Midwest Children's Health Research Institute, Lincoln
Midwest Children's Health Research Institute, Lincoln
Meridian Clinical Research, Hastings
ACC Pediatric Research, Haughton
The Children's Clinic of Jonesboro, P.A., Jonesboro
Ventavia Research Group, Burleson
Ventavia, Houston
Kool Kids Pediatrics, Houston
Pediatric Associates, Houston
Pediatric Center, Richmond
Alliance for Multispecialty Research, Layton
Alliance for Multispecialty Research, Roy
Alliance for Multispecialty Research, Syracuse
Alliance for Multispecialty Research, Murray
Alliance for Multispecialty Research, Provo
Madera Family Medical Group, Madera
Vaxcyte, Inc.
INDUSTRY